| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/26/1995 | WO1995002326A1 Solutions for tissue preservation and bloodless surgery and methods using same |
| 01/26/1995 | WO1995002324A1 Method of inactivation of viral and bacterial blood contaminants |
| 01/26/1995 | WO1994028014A3 Peptide inhibitors of urokinase receptor activity |
| 01/26/1995 | CA2167409A1 Solutions for tissue preservation and bloodless surgery and methods using same |
| 01/26/1995 | CA2167155A1 Modified alpha-lactalbumin |
| 01/26/1995 | CA2167153A1 Prodrugs of protein tyrosine kinase inhibitors |
| 01/26/1995 | CA2166875A1 Transferrin receptor specific ligand-neuro-pharmaceutical agent fusion proteins |
| 01/26/1995 | CA2166711A1 Bacillus thuringiensis isolates and toxins |
| 01/26/1995 | CA2163114A1 Peptides exhibiting oxytocin antagonistic activity |
| 01/25/1995 | EP0635573A2 Process for the preparation of native human glicentin |
| 01/25/1995 | EP0635518A1 New chondrocyte protein |
| 01/25/1995 | EP0635271A1 Therapeutic kits against proteinacious mediators, method of preparation and pharmaceutical compositions containing them |
| 01/25/1995 | EP0635270A1 Parathyroid hormone and raloxifene for increasing bone mass |
| 01/25/1995 | EP0635132A1 Broadly reactive opsonic antibodies that react with common staphylococcal antigens |
| 01/25/1995 | EP0635068A1 Amplification of human mdm2 gene in human tumors |
| 01/25/1995 | EP0635060A1 Myogenic vector systems |
| 01/25/1995 | EP0635058A1 Protease vaccine against heartworm |
| 01/25/1995 | EP0635029A1 Cartilage matrix protein and methods for use |
| 01/25/1995 | EP0635028A1 Pulmonary surfactant protein fragments |
| 01/25/1995 | EP0635027A1 Peptide t and related peptides in the treatment of inflammation, including multiple sclerosis |
| 01/25/1995 | EP0635026A1 Novel lipophilic oligopeptides with immunomodulating activity |
| 01/25/1995 | EP0635016A1 Benzodiazepine derivatives and protein and polypeptide conjugates thereof |
| 01/25/1995 | EP0634939A1 A combination of neurotrophin and antibody directed toward myelin-associated neurite growth inhibitory protein promotes central nervous system regeneration |
| 01/25/1995 | EP0634935A1 A novel therapy for treating sepsis using a soluble form of recombinant cd14 myelomonocytic antigen |
| 01/25/1995 | EP0634934A1 Method of treatment of hiv-seropositive individuals with dietary whey proteins |
| 01/25/1995 | EP0634896A1 Evaluation and treatment of patients with progressive immunosuppression |
| 01/25/1995 | EP0600875A4 Purification of recombinant apolipoprotein e from bacteria. |
| 01/25/1995 | CN1097597A Cyclosporin soft capsule composition |
| 01/25/1995 | CN1097595A Coated pharmaceutical preparation |
| 01/24/1995 | US5384394 Polypeptides useful for treatment of leukemia or uterus tumors |
| 01/24/1995 | US5384309 Anticoagulants |
| 01/24/1995 | US5384308 Lumicarmine |
| 01/24/1995 | US5384250 Prokaryotic cells |
| 01/24/1995 | US5384132 Stabilized gonadotropin containing preparations |
| 01/24/1995 | US5384128 Nontoxic, nonionic surfactants and hypophilic-lipophilic balance number |
| 01/24/1995 | CA2128647A1 Chondrocyte protein |
| 01/24/1995 | CA1334079C Method of producing lys-plasminogen |
| 01/24/1995 | CA1334064C Process for the preparation of a hypoallergenic whey protein hydrolyzate and food |
| 01/23/1995 | CA2128552A1 Derivatives of 6,7-dihydroxy-4-thiaheptanoic acid and their use |
| 01/23/1995 | CA2128376A1 Parathyroid hormone and raloxifene for increasing bone mass |
| 01/20/1995 | CA2128151A1 Receptors of interleukin-12 and antibodies |
| 01/19/1995 | WO1995002187A1 Cell growth factor receptors |
| 01/19/1995 | WO1995002069A1 Oligonucleotide modulation of protein kinase c |
| 01/19/1995 | WO1995002066A1 Method for inhibiting procoagulant hla-dr of melanoma cells |
| 01/19/1995 | WO1995002065A1 Yeast assay to identify inhibitors of dibasic amino acid processing endoproteases |
| 01/19/1995 | WO1995002057A1 Protein tyrosine kinase and ligands thereof |
| 01/19/1995 | WO1995002054A2 Platelet glycoprotein v gene and uses |
| 01/19/1995 | WO1995002053A1 Purified components of mammalian transcription regulation complexes, and analogs |
| 01/19/1995 | WO1995002052A1 Mammamodulin, a hormone-independent mammary tumor cells specific protein |
| 01/19/1995 | WO1995002045A2 Gelatinase antagonists used for treating cancer |
| 01/19/1995 | WO1995001997A1 RECOMBINANT AND HUMANIZED IL-1β ANTIBODIES FOR TREATMENT OF IL-1 MEDIATED INFLAMMATORY DISORDERS IN MAN |
| 01/19/1995 | WO1995001996A1 Insecticidally effective spider toxin |
| 01/19/1995 | WO1995001995A1 Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices |
| 01/19/1995 | WO1995001994A1 Recombinant ctla4 polypeptides and methods for making the same |
| 01/19/1995 | WO1995001992A1 Compositions for and methods of treating cancer and autoimmune diseases |
| 01/19/1995 | WO1995001990A1 Hemoregulatory penta- or hexapeptides |
| 01/19/1995 | WO1995001806A1 Pro-cytotoxic drug conjugates for anticancer therapy |
| 01/19/1995 | WO1995001804A1 A coagulation factor viii formulation |
| 01/19/1995 | WO1995001803A1 H2 antagonist-gastrointestinal motility agent combinations |
| 01/19/1995 | WO1995001802A1 Growth differentiation factor-7 |
| 01/19/1995 | WO1995001801A1 Growth differentiation factor-6 |
| 01/19/1995 | WO1995001800A1 Cyclic semi-random peptide libraries |
| 01/19/1995 | WO1995001799A1 Compositions and method for modulating fertility |
| 01/19/1995 | WO1995001786A1 Pharmaceutical compositions for hardly soluble active substances |
| 01/19/1995 | WO1995001785A1 Pharmaceutical compositions for hardly soluble active substances |
| 01/19/1995 | WO1995001784A1 H2 antagonist-sucralfate-antiflatulent combinations |
| 01/19/1995 | WO1994026891A3 Purified mammalian flt3 ligands and agonists and antagonists thereof |
| 01/19/1995 | DE4426060A1 Use of thymus peptides |
| 01/19/1995 | CA2166872A1 Platelet glycoprotein v gene and uses |
| 01/19/1995 | CA2166798A1 Pro-cytotoxic drug conjugates for anticancer therapy |
| 01/19/1995 | CA2166730A1 H2 antagonist-gastrointestinal motility agent combinations |
| 01/19/1995 | CA2166058A1 Oligonucleotide modulation of protein kinase c |
| 01/19/1995 | CA2165778A1 Growth differentiation factor-7 |
| 01/19/1995 | CA2165776A1 Growth differentiation factor-6 |
| 01/19/1995 | CA2164100A1 Pharmaceutical preparations for poorly-soluble active agents |
| 01/19/1995 | CA2147873A1 Compositions for and methods of treating cancer and autoimmune diseases |
| 01/19/1995 | CA2144319A1 Recombinant ctla4 polypeptides and methods for making the same |
| 01/19/1995 | CA2141417A1 Mammamodulin, a hormone-independent mammary tumor cells specific protein |
| 01/18/1995 | EP0634175A1 Pharmaceutical combination, containing a renin-angiotensin-system inhibitor and an endothelin antagonist |
| 01/18/1995 | EP0633945A1 ANTIBODIES TO ALPHAvBETA3 INTEGRIN |
| 01/18/1995 | EP0633937A1 Immunization by inoculatioon of dna transcription unit |
| 01/18/1995 | EP0633935A1 Stability-enhanced variants of parathyroid hormone |
| 01/18/1995 | EP0633934A1 Modified cells and method of treatment |
| 01/18/1995 | EP0633933A1 Leucine zippers |
| 01/18/1995 | EP0633931A1 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon |
| 01/18/1995 | EP0633895A1 Oxygen carrier |
| 01/18/1995 | EP0633789A1 Wound dressing, wound plaster or carrier matrix |
| 01/18/1995 | EP0633785A1 Specific detection of cell surface receptor leukocyte adhesion molecule-1 |
| 01/18/1995 | EP0633769A1 Methods of manufacturing high dosage glutathione, the tablets and capsules produced thereby |
| 01/18/1995 | EP0633765A1 Skin care method and composition |
| 01/18/1995 | EP0633764A1 Skin care method and composition |
| 01/18/1995 | EP0576623A4 Binding domains in notch and delta proteins. |
| 01/18/1995 | EP0565567B1 Amides of antibiotic ge 2270 factors |
| 01/18/1995 | EP0542891B1 Biologically active compounds from blue-green algae |
| 01/18/1995 | EP0394296B1 Assay of a body fluid for measuring bone resorption |
| 01/18/1995 | EP0378576B1 Transduced fibroblasts and uses therefor |
| 01/17/1995 | US5382683 Sedative, antiepileptic |
| 01/17/1995 | US5382679 Process for the preparation of glutathione S-acyl derivatives, compounds obtained from said process and an intermediate useful for the preparation thereof |
| 01/17/1995 | US5382664 Benzodiazepine derivatives |
| 01/17/1995 | US5382658 Stability-enhanced variants of parathyroid hormone |